Biomarkers of rheumatoid arthritis: recent progress.

about

Targeted salivary biomarkers for discrimination of periodontal health and disease(s)Integrated biomarker profiling of smokers with periodontitis.Alterations in nucleotide-binding oligomerization domain-2 expression, pathway activation, and cytokine production in Yao syndrome.

P2860

Q35969981-1B36AF21-29D0-4D69-B2F4-B6C324CCD8F0 Q40420502-B4D6A9B4-D152-4122-BA52-6F8018B2E403 Q52689523-3C2A9434-40DB-4490-A007-F18554CCACC7

P2860

Biomarkers of rheumatoid arthritis: recent progress.

Item

http://www.wikidata.org/entity/Q38089869

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Biomarkers of rheumatoid arthritis: recent progress.

@en

type

Item

label

Biomarkers of rheumatoid arthritis: recent progress.

@en

prefLabel

Biomarkers of rheumatoid arthritis: recent progress.

@en

P1476

Biomarkers of rheumatoid arthritis: recent progress.

@en

P2093

Chandra Mohan

http://www.w3.org/2001/XMLSchema#string

Deena Sajitharan

http://www.w3.org/2001/XMLSchema#string

P2860

Autoantibodies to calpastatin (an endogenous inhibitor for calcium-dependent neutral protease, calpain) in systemic rheumatic diseases

Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies

Detection and expression of a cDNA clone that encodes a polypeptide containing two inhibitory domains of human calpastatin and its recognition by rheumatoid arthritis sera

TRAF1-C5 as a risk locus for rheumatoid arthritis--a genomewide study

Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review

Anti-keratin antibodies in rheumatoid arthritis

Advanced glycation end-product (AGE)-damaged IgG and IgM autoantibodies to IgG-AGE in patients with early synovitis

Serum cartilage oligomeric matrix protein (COMP) decreases in rheumatoid arthritis patients treated with infliximab or etanercept

A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis

Does a positive anti-CCP test identify a distinct arthritis entity?

P304

293-305

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/17530059.2010.492828

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tianfu Wu

P577

2010-06-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23496146

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

Biomarkers of rheumatoid arthritis: recent progress.

about

P2860

P2860

Biomarkers of rheumatoid arthritis: recent progress.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921